0

Close
 
Upcoming Allied Market Research
2023
Life Science Reagents Market

Life Science Reagents Market

by Product Type (Cell and Tissue Culture Reagents, Chromatography Reagents, Clinical Chemistry Reagents, Immunoassay Reagents, Molecular Diagnostic Reagents, Microbiology Reagents, Others) and by End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech
Report Code: A12293
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Life Science Reagents Market

Request Now !

Life science reagent is a compound that is often used in a chemical reaction to observe changes and draw out inferences. These reagents are rigorously used to develop a new reactant or determine the cause of an illness or a disease. In addition, they are used in chemical reactions to detect, examine, or measure other substances.

Life science reagents are an integral part of the biotechnology, pharmaceutical, and life science industries where they are primarily used for developing test kits and solutions, different types of assays, and culture media. Other than this, these reagents find their applications in chromatography and spectroscopy.

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the biotechnology industry is expected to witness significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19.

COVID-19 is expected to have a significant impact on the life science reagents market as the supply chain of raw materials required to manufacture these reagents has been disrupted in many countries. In addition, the market growth of life science reagents is declining, as manufacturers of these products have slowed down their production due to the pandemic.

Top Impacting Factors

Life science reagents are often used to determine the cause of a disease. Hence, the rising cases of infectious diseases all over the world is the major factor driving the growth of the life science reagents market.

In addition, lack of healthcare facilities and structures can make different types of infectious diseases fatal, which is the case in most of the underdeveloped and developing countries. This factor is positively influencing the growth of the life science reagents market.

The adoption of life science reagents is increasing in diagnostic laboratories and hospitals is further increasing the growth of the global life science reagents market.

However, high cost of life science reagents and stringent regulatory framework regarding the launch and distribution of these reagents impede the growth of the market.

Key Market Trends

The diagnostic laboratories & hospitals segment is anticipated to hold a major share of the life science reagents market, as the adoption rate for life science reagents has increased in these institutions over the years. The increased adoption rate is attributable to the safety and efficacy of life science reagents.

In 2020, Corning, Inc. launched its 3D clear tissue clearing reagent, which helped expand the 3D cell culture imaging portfolio of the company. The 3D clear tissue clearing reagent helps in rapid and advanced imaging of tissues in three-dimensional cell cultures.

In 2020, Meridian Bioscience, Inc. announced the approval of its SARS-CoV-2 antigens and other related reagents from the U.S. Food and Drug Administration (FDA).

North America dominates the life science reagents market due to high investment in life science projects, new reagents developments, and a presence of sophisticated research & development infrastructure.

Asia-Pacific is expected to witness lucrative growth in the life science reagents market, due to increasing outsourcing activities in the field of life science and the adoption of advanced technological products in nations such as Japan, South Korea, Malaysia, and China.

Key Benefits of the Report

  • This study presents the analytical depiction of the life science reagents industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the market share.
  • The current market is quantitatively analyzed to highlight the growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Life Science Reagents Report

  • Which are the leading players active in the life science reagents market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the life science reagents market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What are life science reagents?
  • What are the current trends and predicted trends?

 Life Science Reagents Market Report Highlights

Aspects Details
By Product Type
  • Cell and Tissue Culture Reagents
  • Chromatography Reagents
  • Clinical Chemistry Reagents
  • Immunoassay Reagents
  • Molecular Diagnostic Reagents
  • Microbiology Reagents
  • Others
By End User
  • Hospitals and Diagnostic Laboratories
  • Academic and Research Institutes
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Sysmex Corporation, Hoffmann-La Roche, BioMerieux SA, Merck KGaA, Abbott, Thermo Fisher Scientific, Inc, Becton, Dickinson and Company, DiaSorin S.p.A, Siemens Healthineers, Danaher Corporation
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: LIFE SCIENCE REAGENTS MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Cell And Tissue Culture Reagents

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Chromatography Reagents

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Clinical Chemistry Reagents

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Immunoassay Reagents

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Molecular Diagnostic Reagents

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Microbiology Reagents

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Others

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

  • CHAPTER 5: LIFE SCIENCE REAGENTS MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals And Diagnostic Laboratories

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Academic And Research Institutes

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Others

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: LIFE SCIENCE REAGENTS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Life Science Reagents Market

        • 6.2.5.1. Market Size and Forecast, By Product Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Life Science Reagents Market

        • 6.2.6.1. Market Size and Forecast, By Product Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Life Science Reagents Market

        • 6.2.7.1. Market Size and Forecast, By Product Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Life Science Reagents Market

        • 6.3.5.1. Market Size and Forecast, By Product Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Life Science Reagents Market

        • 6.3.6.1. Market Size and Forecast, By Product Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Life Science Reagents Market

        • 6.3.7.1. Market Size and Forecast, By Product Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Life Science Reagents Market

        • 6.3.8.1. Market Size and Forecast, By Product Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Life Science Reagents Market

        • 6.3.9.1. Market Size and Forecast, By Product Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Life Science Reagents Market

        • 6.3.10.1. Market Size and Forecast, By Product Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Life Science Reagents Market

        • 6.3.11.1. Market Size and Forecast, By Product Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Life Science Reagents Market

        • 6.4.5.1. Market Size and Forecast, By Product Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Life Science Reagents Market

        • 6.4.6.1. Market Size and Forecast, By Product Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Life Science Reagents Market

        • 6.4.7.1. Market Size and Forecast, By Product Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Life Science Reagents Market

        • 6.4.8.1. Market Size and Forecast, By Product Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Life Science Reagents Market

        • 6.4.9.1. Market Size and Forecast, By Product Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Life Science Reagents Market

        • 6.4.10.1. Market Size and Forecast, By Product Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Life Science Reagents Market

        • 6.4.11.1. Market Size and Forecast, By Product Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Life Science Reagents Market

        • 6.4.12.1. Market Size and Forecast, By Product Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Life Science Reagents Market

        • 6.4.13.1. Market Size and Forecast, By Product Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Life Science Reagents Market

        • 6.5.5.1. Market Size and Forecast, By Product Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Life Science Reagents Market

        • 6.5.6.1. Market Size and Forecast, By Product Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Life Science Reagents Market

        • 6.5.7.1. Market Size and Forecast, By Product Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Life Science Reagents Market

        • 6.5.8.1. Market Size and Forecast, By Product Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Life Science Reagents Market

        • 6.5.9.1. Market Size and Forecast, By Product Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Life Science Reagents Market

        • 6.5.10.1. Market Size and Forecast, By Product Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Hoffmann-La Roche

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Thermo Fisher Scientific, Inc

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Becton, Dickinson And Company

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Abbott

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. BioMerieux SA

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Merck KGaA

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Danaher Corporation

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Siemens Healthineers

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. DiaSorin S.p.A

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Sysmex Corporation

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL LIFE SCIENCE REAGENTS MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL LIFE SCIENCE REAGENTS MARKET FOR CELL AND TISSUE CULTURE REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL LIFE SCIENCE REAGENTS MARKET FOR CHROMATOGRAPHY REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL LIFE SCIENCE REAGENTS MARKET FOR CLINICAL CHEMISTRY REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL LIFE SCIENCE REAGENTS MARKET FOR IMMUNOASSAY REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL LIFE SCIENCE REAGENTS MARKET FOR MOLECULAR DIAGNOSTIC REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL LIFE SCIENCE REAGENTS MARKET FOR MICROBIOLOGY REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL LIFE SCIENCE REAGENTS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL LIFE SCIENCE REAGENTS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL LIFE SCIENCE REAGENTS MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL LIFE SCIENCE REAGENTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL LIFE SCIENCE REAGENTS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL LIFE SCIENCE REAGENTS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA LIFE SCIENCE REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. U.S. LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 18. U.S. LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 19. CANADA LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 20. CANADA LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. MEXICO LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 22. MEXICO LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. EUROPE LIFE SCIENCE REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. EUROPE LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 25. EUROPE LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. FRANCE LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 27. FRANCE LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 28. GERMANY LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 29. GERMANY LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. ITALY LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 31. ITALY LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 32. SPAIN LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 33. SPAIN LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. UK LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 35. UK LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. RUSSIA LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 37. RUSSIA LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. REST OF EUROPE LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 39. REST OF EUROPE LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. ASIA-PACIFIC LIFE SCIENCE REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 41. ASIA-PACIFIC LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 42. ASIA-PACIFIC LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. CHINA LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 44. CHINA LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. JAPAN LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 46. JAPAN LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. INDIA LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 48. INDIA LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. SOUTH KOREA LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 50. SOUTH KOREA LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. AUSTRALIA LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 52. AUSTRALIA LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. THAILAND LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 54. THAILAND LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. MALAYSIA LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 56. MALAYSIA LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. INDONESIA LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 58. INDONESIA LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. REST OF ASIA PACIFIC LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. REST OF ASIA PACIFIC LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. LAMEA LIFE SCIENCE REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 62. LAMEA LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 63. LAMEA LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. BRAZIL LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 65. BRAZIL LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH AFRICA LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH AFRICA LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. SAUDI ARABIA LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 69. SAUDI ARABIA LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. UAE LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 71. UAE LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 72. ARGENTINA LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 73. ARGENTINA LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. REST OF LAMEA LIFE SCIENCE REAGENTS, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 75. REST OF LAMEA LIFE SCIENCE REAGENTS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. HOFFMANN-LA ROCHE: KEY EXECUTIVES
  • TABLE 77. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT
  • TABLE 78. HOFFMANN-LA ROCHE: OPERATING SEGMENTS
  • TABLE 79. HOFFMANN-LA ROCHE: PRODUCT PORTFOLIO
  • TABLE 80. HOFFMANN-LA ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. THERMO FISHER SCIENTIFIC, INC: KEY EXECUTIVES
  • TABLE 82. THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT
  • TABLE 83. THERMO FISHER SCIENTIFIC, INC: OPERATING SEGMENTS
  • TABLE 84. THERMO FISHER SCIENTIFIC, INC: PRODUCT PORTFOLIO
  • TABLE 85. THERMO FISHER SCIENTIFIC, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 87. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 88. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 89. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 90. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. ABBOTT: KEY EXECUTIVES
  • TABLE 92. ABBOTT: COMPANY SNAPSHOT
  • TABLE 93. ABBOTT: OPERATING SEGMENTS
  • TABLE 94. ABBOTT: PRODUCT PORTFOLIO
  • TABLE 95. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. BIOMERIEUX SA: KEY EXECUTIVES
  • TABLE 97. BIOMERIEUX SA: COMPANY SNAPSHOT
  • TABLE 98. BIOMERIEUX SA: OPERATING SEGMENTS
  • TABLE 99. BIOMERIEUX SA: PRODUCT PORTFOLIO
  • TABLE 100. BIOMERIEUX SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. MERCK KGAA: KEY EXECUTIVES
  • TABLE 102. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 103. MERCK KGAA: OPERATING SEGMENTS
  • TABLE 104. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 105. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 107. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 108. DANAHER CORPORATION: OPERATING SEGMENTS
  • TABLE 109. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 110. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. SIEMENS HEALTHINEERS: KEY EXECUTIVES
  • TABLE 112. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
  • TABLE 113. SIEMENS HEALTHINEERS: OPERATING SEGMENTS
  • TABLE 114. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
  • TABLE 115. SIEMENS HEALTHINEERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. DIASORIN S.P.A: KEY EXECUTIVES
  • TABLE 117. DIASORIN S.P.A: COMPANY SNAPSHOT
  • TABLE 118. DIASORIN S.P.A: OPERATING SEGMENTS
  • TABLE 119. DIASORIN S.P.A: PRODUCT PORTFOLIO
  • TABLE 120. DIASORIN S.P.A: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121. SYSMEX CORPORATION: KEY EXECUTIVES
  • TABLE 122. SYSMEX CORPORATION: COMPANY SNAPSHOT
  • TABLE 123. SYSMEX CORPORATION: OPERATING SEGMENTS
  • TABLE 124. SYSMEX CORPORATION: PRODUCT PORTFOLIO
  • TABLE 125. SYSMEX CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL LIFE SCIENCE REAGENTS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL LIFE SCIENCE REAGENTS MARKET
  • FIGURE 3. SEGMENTATION LIFE SCIENCE REAGENTS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN LIFE SCIENCE REAGENTS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALLIFE SCIENCE REAGENTS MARKET
  • FIGURE 11. LIFE SCIENCE REAGENTS MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. LIFE SCIENCE REAGENTS MARKET FOR CELL AND TISSUE CULTURE REAGENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. LIFE SCIENCE REAGENTS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. LIFE SCIENCE REAGENTS MARKET FOR CLINICAL CHEMISTRY REAGENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. LIFE SCIENCE REAGENTS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. LIFE SCIENCE REAGENTS MARKET FOR MOLECULAR DIAGNOSTIC REAGENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. LIFE SCIENCE REAGENTS MARKET FOR MICROBIOLOGY REAGENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. LIFE SCIENCE REAGENTS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. LIFE SCIENCE REAGENTS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 20. LIFE SCIENCE REAGENTS MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. LIFE SCIENCE REAGENTS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. LIFE SCIENCE REAGENTS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 27. COMPETITIVE DASHBOARD
  • FIGURE 28. COMPETITIVE HEATMAP: LIFE SCIENCE REAGENTS MARKET
  • FIGURE 29. Top player positioning, 2022
  • FIGURE 30. HOFFMANN-LA ROCHE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. HOFFMANN-LA ROCHE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. HOFFMANN-LA ROCHE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. THERMO FISHER SCIENTIFIC, INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. THERMO FISHER SCIENTIFIC, INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. THERMO FISHER SCIENTIFIC, INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. BECTON, DICKINSON AND COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. ABBOTT: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. ABBOTT: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. ABBOTT: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. BIOMERIEUX SA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. BIOMERIEUX SA: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. BIOMERIEUX SA: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. MERCK KGAA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. MERCK KGAA: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. SIEMENS HEALTHINEERS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. SIEMENS HEALTHINEERS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. SIEMENS HEALTHINEERS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. DIASORIN S.P.A: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. DIASORIN S.P.A: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. DIASORIN S.P.A: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. SYSMEX CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. SYSMEX CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. SYSMEX CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Life Science Reagents Market

Start reading.
This Report and over 68,245+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers